Domestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...

Ajanta Pharma said the US FDA has issued Form-483 with five observations after inspecting its Paithan manufacturing facility in Maharashtra...

Ajanta Pharma has set May 30 as the record date for its Rs 285 crore share buyback,. The buyback, at a premium of 12.6%, targets 10,28,881 ...

Ajanta Pharma has fixed May 30 as the record date for its buyback of 0.82% of the aggregate paid-up share capital of the company at Rs 2,77...

Ajanta Pharma shares jumped 13% to Rs 2,532 in Friday's trade on BSE after the firm's consolidated net profit increased 66% year-on-year (Y...

Revenue from operations rose to Rs 1,054 crore in the fourth quarter of FY24 as compared with Rs 882 crore in the year-ago period, Ajanta P...

Ajanta Pharma on Thursday announced a Rs 285 crore buyback of up to 10.28 lakh shares through a tender offer at a price of Rs 2,770 — a pre...

Ajanta Pharma Ltd. key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue and Export Incentives for the yea...

Payment of interim dividend of Rs 7/- (350%) per equity share on the face-value of Rs 2/- per share for the Financial Year 2022-23,” said t...

Ajanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 16369.91 Crore) operating in Pharmaceuti...

Ajanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 16207.83 Crore) operating in Pharmaceuti...

Ajanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 15564.46 Crore) operating in Pharmaceuti...

Ajanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 13758.77 Crore) operating in Pharmaceuti...

Ajanta Pharma key Products/Revenue Segments include Pharmaceutical Products, Export Incentives and Other Operating Revenue for the year end...

Revenue from operations rose to Rs 885 crore in the second quarter as compared with Rs 716 crore in the year-ago period, Ajanta Pharma said...

Ajanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 13871.05 Crore) operating in Pharmaceuti...

Ajanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 13656.39 Crore) operating in Pharmaceuti...